AVEO - AVEO Pharmaceuticals, Inc.
0.9600 +0.04 (4.00%)
After hours: 5:53PM EDT
| Previous Close | 0.9430 |
| Open | 0.9300 |
| Bid | 0.9510 x 1000 |
| Ask | 0.9600 x 900 |
| Day's Range | 0.9000 - 0.9650 |
| 52 Week Range | 0.4900 - 3.5900 |
| Volume | 3,694,362 |
| Avg. Volume | 8,476,964 |
| Market Cap | 148.378M |
| Beta (3Y Monthly) | 0.93 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.1930 |
| Earnings Date | May 11, 2017 - May 12, 2017 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 1.75 |
- ACCESSWIRE•2 hours ago
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Aveo Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline – AVEO
NEW YORK, NY / ACCESSWIRE / April 23, 2019 / Pomerantz LLP announces that a class action lawsuit has been filed against Aveo Pharmaceuticals, Inc. (''Aveo'' or the ''Company'') (AVEO) and certain of its officers and directors. The class action, filed in United States District Court, Southern District of New York, and indexed under 19-cv-01722, is on behalf of a class consisting of all persons and entities, other than Defendants and their affiliates, who purchased or otherwise acquired AVEO securities between August 4, 2016 through January 31, 2019, both dates inclusive (the ''Class Period''), seeking to recover damages caused by Defendants' violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the ''Exchange Act'') and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officials.
- Business Wire•2 hours ago
AVEO Oncology Announces $2M Milestone Payment From EUSA Pharma Related To Commercialization of FOTIVDA® in Spain
AVEO Oncology (AVEO) today announced the triggering of a $2 million milestone payment to AVEO from EUSA Pharma. The milestone payment relates to the reimbursement approval and commercial launch in Spain of FOTIVDA® (tivozanib) as a first line treatment of adult patients with advanced renal cell carcinoma (RCC). Commercial launch in Spain is the third of five EU5 country launches to trigger a $2 million payment under the terms of AVEO’s license agreement with EUSA Pharma.
- ACCESSWIRE•3 hours ago
SHAREHOLDER ALERT: AVEO BA S: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
NEW YORK, NY / ACCESSWIRE / April 23, 2019 / The Law Offices of Vincent Wong announce that class actions have commenced on behalf of shareholders of the following companies. If you suffered a loss you ...
- GlobeNewswire•3 hours ago
Class Action Alert CAG, DPLO & AVEO Bronstein, Gewirtz & Grossman, LLC
NEW YORK, April 23, 2019 -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following.
- ACCESSWIRE•7 hours ago
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of AVEO, DPLO and EB
NEW YORK, NY / ACCESSWIRE / April 23, 2019 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. If you suffered a loss you have ...
- ACCESSWIRE•8 hours ago
Final Deadline CAG, DPLO & AVEO Bronstein, Gewirtz & Grossman, LLC
NEW YORK, NY / ACCESSWIRE / April 23, 2019 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies. You can review ...
- ACCESSWIRE•4 days ago
FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of AVEO, SYNH and INGN
CEDARHURST, NY / ACCESSWIRE / April 19, 2019 / The securities litigation law firm of Kuznicki Law PLLC issues the following notice on behalf of shareholders of the following publicly traded companies. Shareholders who purchased shares in these companies during the dates listed below are encouraged to contact the firm regarding possible appointment as lead plaintiff and a preliminary estimate of their recoverable losses. If you wish to choose counsel to represent you and the class, you must apply to be appointed lead plaintiff and be selected by the Court.
- ACCESSWIRE•4 days ago
FINAL DEADLINE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against AVEO Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / April 19, 2019 / The Schall Law Firm , a national shareholder rights litigation firm, announces the filing of a class action lawsuit against AVEO Pharmaceuticals, Inc. (''AVEO'' ...
- GlobeNewswire•4 days ago
SHAREHOLDER ALERT: CORT AVEO MBT ARA: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
NEW YORK, April 19, 2019 -- The Law Offices of Vincent Wong announce that class actions have commenced on behalf of shareholders of the following companies. If you suffered a.
- ACCESSWIRE•5 days ago
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Aveo Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline - AVEO
NEW YORK, NY / ACCESSWIRE / April 18, 2019 / Pomerantz LLP announces that a class action lawsuit has been filed against Aveo Pharmaceuticals, Inc. ("Aveo" or the "Company") (AVEO) and certain of its officers and directors. The class action, filed in United States District Court, Southern District of New York, and indexed under 19-cv-01722, is on behalf of a class consisting of all persons and entities, other than Defendants and their affiliates, who purchased or otherwise acquired AVEO securities between August 4, 2016 through January 31, 2019, both dates inclusive (the "Class Period"), seeking to recover damages caused by Defendants' violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the "Exchange Act") and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officials.
- ACCESSWIRE•5 days ago
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of AVEO, CTL and WSR
NEW YORK, NY / ACCESSWIRE / April 18, 2019 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. If you suffered a loss you have ...
- GlobeNewswire•5 days ago
APR 26 DEADLINE NOTICE: Pawar Law Group Announces a Securities Class Action Lawsuit Against AVEO Pharmaceuticals, Inc. – AVEO
Pawar Law Group announces that a class action lawsuit has been filed on behalf of shareholders who purchased shares of AVEO Pharmaceuticals, Inc. (AVEO) from August 4, 2016 through January 31, 2019, inclusive (the “Class Period”). The lawsuit seeks to recover damages for AVEO investors under the federal securities laws. If you wish to serve as lead plaintiff, you must move the Court no later than April 26, 2019.
- ACCESSWIRE•5 days ago
IMPORTANT DEADLINE REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against AVEO Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / April 18, 2019 / The Schall Law Firm , a national shareholder rights litigation firm, announces the filing of a class action lawsuit against AVEO Pharmaceuticals, Inc. (''AVEO'' ...
- GlobeNewswire•5 days ago
CLASS ACTION UPDATE for CORT, AVEO, DPLO and MBT: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
NEW YORK, April 18, 2019 -- Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies..
- Zacks•5 days ago
AVEO Pharmaceuticals Down More Than 40% in 90 Days: Here's Why
AVEO Pharmaceuticals (AVEO) suffers a major hindrance as it defers its NDA filing for Fotivda in the United States.
- Zacks•5 days ago
Will AVEO Pharmaceuticals Continue to Surge Higher?
As of late, it has definitely been a great time to be an investor in AVEO Pharmaceuticals.
- ACCESSWIRE•6 days ago
FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of AVEO, AMRN and CVS
CEDARHURST, NY / ACCESSWIRE / April 17, 2019 / The securities litigation law firm of Kuznicki Law PLLC issues the following notice on behalf of shareholders of the following publicly traded companies. ...
- ACCESSWIRE•6 days ago
INVESTOR ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against AVEO Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / April 17, 2019 / The Schall Law Firm , a national shareholder rights litigation firm, announces the filing of a class action lawsuit against AVEO Pharmaceuticals, Inc. (''AVEO'' ...
- ACCESSWIRE•7 days ago
CLASS ACTION UPDATE for AVEO, CAG and WTW: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
NEW YORK, NY / ACCESSWIRE / April 16, 2019 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders ...
- ACCESSWIRE•7 days ago
SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against AVEO Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / April 16, 2019 / The Schall Law Firm , a national shareholder rights litigation firm, announces the filing of a class action lawsuit against AVEO Pharmaceuticals, Inc. (''AVEO'' ...
- GlobeNewswire•7 days ago
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of AVEO, DPLO, UMC and NIO
NEW YORK, April 16, 2019 -- The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. If you suffered a.
- ACCESSWIRE•7 days ago
Class Action Deadline CAG, DPLO & AVEO Bronstein, Gewirtz & Grossman, LLC
NEW YORK, NY / ACCESSWIRE / April 16, 2019 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies. You can review ...
- ACCESSWIRE•8 days ago
CLASS ACTION UPDATE for AVEO, DPLO and VNDA: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
NEW YORK, NY / ACCESSWIRE / April 15, 2019 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders ...
- Zacks•8 days ago
AVEO Pharmaceuticals (AVEO) Dips More Than Broader Markets: What You Should Know
AVEO Pharmaceuticals (AVEO) closed at $1 in the latest trading session, marking a -1.96% move from the prior day.
